ACRYSOF® Restor Apodized Diffractive IOL Postmarket Evaluation of Clinical Outcomes and Life-Style Visual Performance RESTOR IOL SN60WF IOL (Control Group)

PHASE4

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped Verified with former investigator that recruitment activity did not take place

Conditions

PROCEDURE: Clinical visual outcomes of bilateral implantation of Restore Intra Ocular Lens.

University of Texas Southwestern Medical Center